Dolutegravir approved in Wales
Dolutegravir, in combination with other antiretrovirals, has been approved for use in NHS Wales by the All Wales Medicines Strategy Group to treat HIV infection in those aged 12 years and over.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20066636
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com